In this video, I read an article written by Dr. Fred Lublin and Stephen Krieger on the so-called multiple sclerosis treatment era, the time since the approval of betaseron by the FDA in 1993. How have things changed in the last 30 years? What do we know, and what are we still debating? Where do we go from here?

Comment or ask questions below! I would be happy to answer!
Subscribe on YouTube for more videos every Wednesday!
Make video requests in the comments section!

Check out my book “Resilience in the Face of Multiple Sclerosis” FREE on Amazon: [ Ссылка ] It's about 5 people with MS who live incredible lives, the science and psychology of resilience, mindfulness, and ho’oponopono. Paperback priced to generate $0 royalty.

Dr. Brandon Beaber is a board-certified neurologist with subspecialty training in multiple sclerosis and other immunological diseases of the nervous system. He is a partner in the Southern California Permanente Medical Group and practices in Downey, California (South Los Angeles). He has several publications on MS epidemiology and has participated in clinical trials for MS therapeutics. You can follow him on twitter @Brandon_Beaber where he regularly posts about MS news and research.

Follow me on twitter: [ Ссылка ]

Music: INNER GRACE - Copyright 2018 Wilton Vought Source: Really Really Free Music Link: [ Ссылка ] T

he video material by Dr. Brandon Beaber is general educational material on health conditions and is not intended to be used by viewers to diagnose or treat any individual's medical condition. Specifically, this material is not a substitute for individualized diagnostic and treatment advice by a qualified medical/health practitioner, licensed in your jurisdiction, who has access to the relevant information available from diagnostic testing, medical interviews, and a physical examination. To the extent that Dr. Beaber endorses any lifestyle change, behavioral intervention, or supplements, the viewer should consult with a qualified healthcare professional to determine the safety and efficacy of the intervention in light of their individualized information.

свернуть